Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek

26 March 2025

Innovator Insight

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

20 March 2025

Innovator Insight

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn

10 March 2025

Innovator Insight

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Phil Morton, Shanya Jiang

03 March 2025

Innovator Insight

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Robotic gloveless isolator technology enhances regional production of advanced therapeutics

Zach Hartman, Peter Boman

27 February 2025

Innovator Insight

Maximizing cell therapy process flexibility and efficiency with next-generation technologies

19 February 2025

Innovator Insight

Speeding to success: accelerating cell therapy development and manufacturing workflows

17 February 2025

Innovator Insight

Toward clinical-scale nonviral gene-edited CAR-NK cells for cell therapy

Namritha Ravinder, Krishanu Saha

13 February 2025

Innovator Insight

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Tamara Laskowski, Nuala Trainor

06 February 2025

Innovator Insight

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Soong Poh Loong, Paula Lam

28 January 2025

Innovator Insight

Closed system solutions for cell and gene therapy manufacturing

Anette Funfak

05 December 2024

Innovator Insight

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann

04 December 2024

Innovator Insight

From the lab to the bench: scaling up regulatory T cell therapy

Megan Levings, Hany Meås

26 November 2024

Innovator Insight

Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy

Therese Choquette, Minh Ngoc Duong

25 November 2024

Innovator Insight

Optimizing bioprocess purification: effective nucleic acid removal in high salt environments

Eleonora Turco, Joanna Niska-Blakie

30 October 2024

Innovator Insight

Extracellular vesicles: setting your path to IND with advanced characterization packages

Davide Zocco

28 October 2024

Innovator Insight

How will process development and analytical innovation drive growth for the future of cell and gene therapies?

Mark Santos

07 October 2024

Innovator Insight

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Joanna Kern

01 October 2024

Innovator Insight

Navigating cold chain complexity to enable clinical-to-commercial transition of advanced therapies

Susan Li

26 September 2024

Innovator Insight

Enhancing CAR-T cell generation: optimizing non-viral engineering of resting T cells for improved cancer immunotherapy

Akshaya Chandrasekaran

12 September 2024

Innovator Insight